The scientific journal PLOS ONE has published an article with extensive information on antibodies to SARS-CoV-2 derived from bovine colostrum. Efficiency, safety and relevance data have been shared. During the time of pandemic, that has affected us all, this article is of great importance. Information is available on the entire concept, as well as on possible implementation measures to develop safe and effective products as an alternative additional measure to combat the spread of the virus.
BioBlock nasal spray, which has received a lot of recognition and support, contains antibodies to SARS-CoV-2 derived from bovine colostrum. This is thoroughly reviewed in the article. The ability of the antibodies to neutralize all known strains of SARS-CoV-2, including the current Omicron strain, is also described.
Why is publishing this article important? The renowned scientific journals check the entire content very carefully before publication. Everything must be proven! Publication in a scientific journal confirms what the Estonian team has achieved and introduces the necessary content of this concept.
To read the article, click HERE
The article has been published thanks to the joint effort of Estonian researchers, universities and the companies that created BioBlock. Many thanks to Icosagen Grupp, OÜ Teadus ja Tegu, Estonian University of Life Sciences, University of Tartu and AS Chemi-Pharm.
Together with vaccines, disinfection, wearing masks and distancing, BioBlock is necessary protective measure that helps in the fight against virus.
Read more about BioBlock: https://www.medihex.com/en/products/bioblock/